• Users Online: 105
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 
ORIGINAL ARTICLE
Year : 2021  |  Volume : 41  |  Issue : 4  |  Page : 161-166

Cutaneous adverse drug reactions in a tertiary hospital in Taipei, Taiwan, in 2018


1 Department of Dermatology, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan
2 Department of Dermatology, National Defense Medical Center, Tri-Service General Hospital, Taipei; Department of Dermatology, Armed-Forces Taoyuan General Hospital, Taoyuan, Taiwan
3 Department of Internal Medicine, Division of Rheumatology/Immunology/Allergy, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan
4 Department of Pharmacy Practice, Tri-Service General Hospital; National Defense Medical Center, School of Pharmacy, Taipei, Taiwan
5 Department of Pharmacy Practice, Tri-Service General Hospital, Taipei, Taiwan
6 Department of Dermatology, National Defense Medical Center, Tri-Service General Hospital; National Defense Medical Center, Graduate Institute of Medical Sciences, Taipei, Taiwan

Correspondence Address:
Dr. Chih-Tsung Hung
Department of Dermatology, Tri-Service General Hospital, National Defense Medical Center, No. 325, Sec. 2, Chenggong Road, Neihu Dist., Taipei City 114
Taiwan
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: :10.4103/jmedsci.jmedsci_172_19

Rights and Permissions

Cutaneous adverse drug reactions (CADRs) are the common adverse reactions ranging from mild self-limiting skin rash to the life-threatening severe cutaneous adverse reactions. Aims: The aim of the study was to describe the demographic characteristics of patients, different clinical patterns, and implicated drugs. Methods: This was a retrospective study by analyzing the database established for all ADRs reported from January 1, 2018, to December 31, 2018, in a tertiary care teaching hospital in Taipei, Taiwan. Results: A total of 126 cases of CADRs were reported in 2018. The mean age of patients was 59.06 ± 21.63 years, with a peaking at 60–79-year-old (31.7%) and followed by 40–59-year-old (25.4%). The male-to-female ratio was 1.03:1. The most common skin reaction pattern was maculopapular eruptions (59.5%), followed by angioedema (11.9%), phlebitis (6.3%), and urticaria (6.3%). Most of the CADRs were reported with antibacterials (66.7%), followed by anti-inflammatory products (11.9%), contrast media (4.8%), and antithrombotic agents (3.2%). Conclusions: We listed the patient characteristics, each pattern of CADRs, and their associated drugs. Such information could help health-care professionals to assess CADRs and evaluate suspected drugs timely and accurately.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2470    
    Printed109    
    Emailed0    
    PDF Downloaded337    
    Comments [Add]    

Recommend this journal